Abstract
In recent years an increasing amount of interest has been directed at the study and routine testing of polymorphisms responsible for variations in drug metabolism. Most of the current methods involve either time-consuming electrophoresis steps or specialized and expensive equipment. In this context, we have developed a rapid, simple and robust method for genotyping of CYP2D6*3, CYP2D6*4, CYP2C19*2, CYP2C19*3 and TPMT*2 single nucleotide polymorphisms (SNP). Genomic DNA is isolated from whole blood and the segments that span the SNP of interest are amplified by PCR. The products are subjected directly (without purification) to two primer extension (PEXT) reactions (three cycles each) using normal and mutant primers in the presence of biotin-dUTP. The PEXT primers contain a (dA)30 segment at the 5′ end. The PEXT products are detected visually by a dry-reagent dipstick-type assay in which the biotinylated extension products are captured from immobilized streptavidin on the test zone of the strip and detected by hybridization with oligo(dT)-functionalized gold nanoparticles. Patient samples (76 variants in total) were genotyped and the results were fully concordant with those obtained by direct DNA sequencing.
Similar content being viewed by others
References
Gurwitz D, Lunshof JE, Dedoussis G, Flordellis CS, Fuhr U, Kirchheiner J, Licinio J, Llerena A, Manolopoulos VG, Sheffield LJ, Siest G, Torricelli F, Vasiliou V, Wong S (2005) Pharmacogenomics J 5:221–225
Shastry BS (2006) Pharmacogenomics J 6:16–21
Steimer W, Muller B, Leucht S, Kissling W (2001) Clin Chim Acta 308:33–41
Testa B, Kramer SD (2007) Chem Biodivers 4:257–405
Scordo MG, Caputi AP, D’Arrigo C, Fava G, Spina E (2004) Pharmacol Res 50:195–200
Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ (1989) Am J Hum Genet 45:889–904
Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F (1997) Pharmacogenetics 7:193–202
Steijns LSW, Van Der Weide J (1998) Clin Chem 44:914–917
Muller B, Zopf K, Bachofer J, Steimer W (2003) Clin Chem 49:1624–1631
Daly AK (2003) Fundam Clin Pharmacol 17:27–41
Fletcher B, Goldstein DB, Bradman ALR, Weale ME, Bradman N, Thomas MG (2003) Genomics 81:166–174
Koski A, Sistonen J, Ojanpera I, Gergov M, Vuori E, Sajantila A (2006) Forensic Sci Int 158:177–183
Zand N, Tajik N, Hoormand M, Moghaddam AS, Milanian I (2005) Iranian J Pharmacol Ther 4:124–127
Chauhan N, Rani S, Padh H (2007) Indian J Pharm Sci 69:180–189
Coulthard SA, Hall AG (2001) Pharmacogenomics J 1:254–261
Sandborn WJ (2004) Inflamm Bowel Dis 10:S35–S37
Reuther LO, Vainer B, Sonne J, Larsen NE (2004) Eur J Clin Pharmacol 59:797–801
Ishiguro A, Kubota T, Soya Y, Sasaki H, Yagyu O, Takarada Y, Iga T (2005) Anal Biochem 337:256–261
Roberts RL, Kennedy MA (2006) Clin Chim Acta 366:348–351
Daly AK, King BP, Leathart JB (2006) Methods Mol Biol 320:193–207
Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N et al (1998) Hum Mutat 12:177–185
Schaeffeler E, Lang T, Zanger UM, Eichelbaum M, Schwab M (2001) Clin Chem 47:548–555
Bathum L, Hansen TS, Horder M, Brosen KA (1998) Ther Drug Monit 20:1–6
Eriksson S, Berg LM, Wadelius M, Alderborn A (2002) Assay Drug Dev Technol 1:49–59
Nevilie M, Selzer R, Aizenstein B, Maguire M, Hogan K, Walton R, Welsh K, Neri B, de Arruda M (2002) Biotechniques Suppl 34–8:40–43
Misra A, Hong JY, Kim S (2007) Clin Chem 53:933–939
Nasedkina TV, Fedorova OE, Glotov AS, Chupova NV, Samochatova EV, Maiorova OA, Zemlyakova VV, Roudneva AE, Chudinov AV, Yurasov RA, Kozhekbaeva JM, Barsky VE, Krynetskiy EY, Krynetskaia NF, Cheng C, Ribeiro RC, Evans WE, Roumyantsev AG, Zasedatelev AS (2006) Eur J Hum Genet 14:991–998
Lu Yi, Kow-Yin Kham S, Foo TC, Hany AY, Quah TC, Yeoh AEJ (2007) Anal Biochem 360:105–113
Litos IK, Ioannou PC, Christopoulos TK, Traeger-Synodinos J, Kanavakis J (2007) Anal Chem 79:395–402
Hiratsuka M, Ebisawa A, Matsubara Y, Kure S, Konno Y, Sasaki T, Mizugaki M (2004) Drug Metab Pharmacokin 19:303–307
Matsubara Y, Kure S (2003) Hum Mutat 22:166–172
Acknowledgements
This work was supported by a University–Industry collaboration grant (EPAN) funded by the General Secretariat of Research and Technology (GSRT) of Greece and by Medicon Hellas S.A. (Gerakas, Greece 15344).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Litos, I.K., Emmanouilidou, E., Glynou, K.M. et al. Rapid genotyping of CYP2D6, CYP2C19 and TPMT polymorphisms by primer extension reaction in a dipstick format. Anal Bioanal Chem 389, 1849–1857 (2007). https://doi.org/10.1007/s00216-007-1593-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-007-1593-4